|
the potential for FDA approved (Fanapt) is ~$5 billion annually in sales. two companies own the rights to revenues/royalties; VNDA & TTNP.pk
TTNP.pk is trading ~$1.45 and should fetech $15+ ps from a buyout of their royalty stream VNDA trades ~$12; they can produce the drug alone or if bought out could fetch ~$20+ ps from a buyout of their revenue stream Novartis owns ~10-15% in royalties from Fanapt also. TTNP is a bargain, imo! Sentiment : Strong Buy Rating :
 (No ratings) |
28/Female |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|